Returns | 1W : -0.1% , 1M : 5.5%,1Y : 56.9% |
LT :   |
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap] Debt : Low |
ST :   |
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Peers & Returns | 1W | 1M | 1Y |
SUN PHARMACEUTICAL INDUSTRIES LTD | -0.1% | 5.5% | 56.9% |
DR REDDYS LABORATORIES LTD | -0.8% | -9.3% | 44.9% |
DIVIS LABORATORIES LTD | -3.6% | -1.7% | 62.4% |
CIPLA LTD | -0.8% | -6.5% | 90.2% |
BIOCON LTD | -1.9% | 2.6% | 30.9% |
AUROBINDO PHARMA LTD | -0.4% | -9.5% | 71.2% |
LUPIN LTD | 2.3% | -3% | 53% |
TORRENT PHARMACEUTICALS LTD | -0.5% | -8.8% | 11.5% |
CADILA HEALTHCARE LTD | 0.4% | -5.9% | 60.8% |
Ratio | Value |
---|---|
P/E P/B P/S |
37.94
P/E Calculated based on EPS of 15.69
[ Mar2020 - Consolidated Results ] 3.16
P/B Calculated based on Book Value of 188.66
[ Mar2020 - Consolidated Results ] 4.46
P/S Calculated based on Revenues of 32048.4 Cr
[ TTM - Consolidated Results ] |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
108% -37% -39% |
Pledged Shares |
9.09 % |
---|---|
As on : Sep2020 | |
If less than 25% | Good |
If between 25% and 50% | Neutral |
If greater than 50% | Bad |